NIAID

Science, where are we going? From intellectual passion to a market-driven system

With over 10 million active researchers, more than 2 million scientific articles published each year, and an uncontrolled spread of bibliometric …

Research

Is Your Food Reaction an Allergy or an Intolerance? Here's How to Tell the Difference

If you’ve ever had a surprising physical reaction to a food you’ve enjoyed your entire life, you’re not alone. According to <i>Consumer Reports</i>, food …

Food Allergies

NIH launches study to test combination antibody treatment for HIV infection

News Release<p>Thursday, September 20, 2018<p>A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the …

Medicine

Scientists weigh Zika vaccine challenge study after case count plummets: report

Zika captured the world's attention when microcephaly cases started popping up in Brazil back in 2015, and in a fast response, governments and …

Public Health

Enable Biosciences Awarded NIH/NIAID Grant to Advance Minimally-Invasive Multiplex Food Allergy Test Panel

SAN FRANCISCO, Sept. 20, 2018 /PRNewswire/ -- <b>Enable Biosciences Inc.</b> has been awarded a National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Small Business Innovation Research (SBIR) Phase I grant for<b>$223,806</b>to accelerate development of its <b>minimally</b> …

Viruses

Conflicting evidence for HIV enrichment in CD32<sup>+</sup> CD4 T cells

Access optionsAccess options<p>References<p>1.<p>Descours, B. et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent …

Viruses

Experimental nasal influenza vaccine tested in kids, teens

News Release<p>Monday, September 17, 2018<p>NIH-supported Phase 1 trial of potential broadly protective vaccine.<p>An early-stage clinical trial testing the …

Medicine

BioCryst Receives Additional $3.5 Million to Fund Clinical Trials of Galidesivir in Yellow Fever

RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded BioCryst an additional $3.5 million to support …

Clinical Trials

E. coli's adaptation to extreme temperatures helps explain resistance to certain drugs

Long before bacteria had to contend with antibiotic drugs, they had to survive extreme temperatures as Earth warmed and cooled over millennia. Could …

E.coli

NIAID and Children's National partner to advance pediatric clinical research

Inaugural symposium highlights collaboration in allergic, immunologic and infectious disease research<p>The National Institute of Allergy and Infectious …

Viruses

As massive Zika vaccine trial struggles, researchers revive plan to intentionally infect humans

In 2016, as the mosquito-borne Zika virus spread through the Americas and cases of infected women having brain-damaged babies mounted, investigators …

Zika Virus

Largest study of 'post-treatment controllers' reveals clues about HIV remission

Some HIV patients maintain low viral loads after stopping treatment; early treatment and HIV reservoir size may be the keys<p>Most HIV patients need to …

Harvard

Plan cuts mortality for people with HIV who inject drugs

A new intervention for people living with HIV who inject drugs led to an increase in people taking their medications and a decrease in mortality, …

Health

Junior investigators successfully compete for extra NIH grants

More than half of early-career scientists who received their first research project (R01) grants from the National Institute of Allergy and …

Viruses

The top doctor-approved time to get your flu shot is coming up soon

Along with pumpkin spice everything, crisp outdoors runs, and anything-but-basic sweaters-and-leggings combos, fall also spells flu season. Early …

Lifestyle

Early stage clinical trial of antimalarial drug begins

News Release<p>Monday, September 10, 2018<p>Enrollment has begun in a Phase 1 clinical trial to test the safety of a new investigational drug designed to …

Medicine

Sepsis can kill before you know it, so it’s wise to know the symptoms

<b>Sepsis awareness</b><p>Infection can set off a chain reaction that quickly causes death<p>The human immune system is a wonder, an intricately constructed network of organs, cells and biological processes designed to ward off infection and disease.<p>But sometimes the system goes into overdrive, leading to …

Medicine

Engineered Protein May Lead to New Parkinson’s Therapy, Preclinical Study Suggests

A modified form of a protein called Nurr1 that is able to protect against nerve cell death and restore dopamine production in a preclinical setting …

Neuroscience

Journey to explore the inexhaustible resource of genetic information found in microorganisms

The microbial production of enzymes, chemicals and fuels could become more efficient and economical with a newly engineered system for controlling …

Molecular Biology

Clinical trial testing topical cream plus influenza vaccine in progress: Cream regimen could boost immunity

Cream regimen could boost immunity<p>A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a …

Public Health

Myths — and facts — about childhood food allergies

When someone has a food allergy, one bite of the wrong food could actually be fatal. It’s a heavy and terrifying burden. Further complicating matters …

Food Allergies

New Research for Atopic Dermatitis

Atopic dermatitis (AD) isn’t a new condition, but new research is paving the way for better, more effective treatments. The latest research is …

Medical Research

Bacterial Factors That Predict Relapse after Tuberculosis Therapy

Approximately 5% of patients with drug-susceptible tuberculosis have a relapse after 6 months of first-line therapy, and approximately 20% of …

Medicine

Novel intervention halves rate of death among people living with HIV who inject drugs

NIH-supported study finds intervention boosts treatment participation, HIV suppression<p>An intervention designed to facilitate treatment for HIV and …

Public Health

Peanut allergies and airlines

Most of the questions I get from you, dear readers, are easy, such as Skip’s inquiry (in the spirit of my corny joke column), “How do you know when …

Diets

HIV/AIDS research yields dividends across medical fields

Media Advisory<p>Tuesday, August 28, 2018<p>Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer and other …

Medicine

A new take on fighting multi-drug resistant bacteria

UH researchers receive $3.5 M to find best combinations of antibiotics<p>Two UH researchers have won a five-year, $3.5 million grant from the National …

Medicine

UTEP scientists awarded $6 million to improve treatment for Chagas disease

Scientists at The University of Texas at El Paso have received nearly $6 million from the National Institutes of Health (NIH) to improve treatment …

Chagas Disease

Secret Tunnels Between Skull, Brain Speed Immune Cells After Stroke in Mice

MONDAY, Aug. 27, 2018 (HealthDay News) -- Immune cells use channels that run from skull bone marrow to the lining of the brain to rapidly respond to …

Immune System

HIV can be suppressed with antiretroviral therapy. Why isn’t everyone using it?

A daily regime of antiretroviral therapy to suppress HIV can be lifesaving to those living with HIV, and helps prevent its spread. But why is it so …

Antiretroviral Therapy